Logo (Actavis) 435 (Lamotrigine Extended-Release 50 mg)
Pill with imprint Logo (Actavis) 435 is Gray, Round and has been identified as Lamotrigine Extended-Release 50 mg. It is supplied by Actavis Pharma, Inc..
Lamotrigine is used in the treatment of bipolar disorder; borderline personality disorder; epilepsy; seizure prevention; schizoaffective disorder (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 435
Lamotrigine Extended-Release
- Imprint:
- Logo (Actavis) 435
- Strength:
- 50 mg
- Color:
- Gray
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00228-1435
More about lamotrigine
- Lamotrigine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 903 Reviews
- Drug class: triazine anticonvulsants
Consumer resources
- Lamotrigine
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Lamotrigine (Advanced Reading)
Other brands: Lamictal, Lamictal XR, Lamictal ODT, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
